Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.
about
Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaStructural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175Decline in childhood iron deficiency after interruption of malaria transmission in highland Kenya.Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens.Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria.The epitope of monoclonal antibodies blocking erythrocyte invasion by Plasmodium falciparum map to the dimerization and receptor glycan binding sites of EBA-175.Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of responseNatural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon.New antigens for a multicomponent blood-stage malaria vaccineAge-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity.Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in ChildrenA quantitative assay for binding and inhibition of Plasmodium falciparum Erythrocyte Binding Antigen 175 reveals high affinity binding depends on both DBL domains.Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique.Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana.Editorial Commentary: Toward a Better Malaria Vaccine: Understanding How Antibodies to Malaria Protect Against Disease.Assessment of the quality and quantity of naturally induced antibody responses to EBA175RIII-V in Ghanaian children living in two communities with varying malaria transmission patterns.Mechanisms of naturally acquired immunity to P. falciparum and approaches to identify merozoite antigen targets.
P2860
Q26772878-B110829E-C3E1-4F6B-B0F4-F014B5A4693EQ27678372-2B5D7BD8-0D4C-458A-89AA-45F4C1A3617BQ34056231-ABD0F0FB-227A-4883-B25E-F03D1ACC43E5Q34209043-30CB939D-B0CA-4929-BB75-A6B23886D201Q34515219-5B82A77D-72EE-483C-A539-EECA38988413Q34606720-DAEAABA7-E6E2-46BD-AE7E-E78B6E372E7EQ34955461-0F2486ED-708A-4672-8001-A07968A2C6CDQ35076906-17CBAD14-3581-42E4-AA48-97D779E3046DQ35216634-5EAA87A9-1BBC-4E9D-BBE4-81FEA480FAE5Q35739071-05D9D82F-C2E1-4D6E-AAB1-484982A7A663Q37148056-6820CFE6-7E1D-4CD0-B182-CBBABB7C58E3Q37202344-82F85326-59C9-4C4D-992D-80C290621856Q37220749-BE6EE886-9BFA-45EA-8796-87BAEDC299D8Q37632441-2CF996D2-3B36-475E-8B1B-C3053A917250Q37702603-CCE2F10B-2B82-46DA-AAA0-3BCC5AEC5537Q41994486-5821D2EE-ED2A-4F0B-99B5-2195CD008483Q44482507-2644C298-1BCF-4569-A799-5878F57E6323Q47347281-7552AB92-6D2A-4E8E-9469-FE14199AE595Q47396685-6FD0AB70-D8BE-4454-83C9-EFD57E2838DE
P2860
Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Antibodies to Plasmodium falci ...... tection from clinical malaria.
@ast
Antibodies to Plasmodium falci ...... tection from clinical malaria.
@en
type
label
Antibodies to Plasmodium falci ...... tection from clinical malaria.
@ast
Antibodies to Plasmodium falci ...... tection from clinical malaria.
@en
prefLabel
Antibodies to Plasmodium falci ...... tection from clinical malaria.
@ast
Antibodies to Plasmodium falci ...... tection from clinical malaria.
@en
P2093
P2860
P50
P1476
Antibodies to Plasmodium falci ...... tection from clinical malaria.
@en
P2093
Ann M Moormann
George Ayodo
Matthew B McCarra
Peter O Sumba
P2860
P304
P356
10.1097/INF.0B013E31822D1451
P577
2011-12-01T00:00:00Z